Adial Pharmaceuticals Statistics
Total Valuation
ADIL has a market cap or net worth of $6.37 million. The enterprise value is $3.42 million.
| Market Cap | 6.37M |
| Enterprise Value | 3.42M |
Important Dates
The next estimated earnings date is Tuesday, May 21, 2024, after market close.
| Earnings Date | May 21, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ADIL has 4.05 million shares outstanding. The number of shares has increased by 42.25% in one year.
| Shares Outstanding | 4.05M |
| Shares Change (YoY) | +42.25% |
| Shares Change (QoQ) | +20.88% |
| Owned by Insiders (%) | 4.04% |
| Owned by Institutions (%) | 6.53% |
| Float | 3.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.53 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.90, with zero debt.
| Current Ratio | 4.90 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -183.30% and return on invested capital (ROIC) is -168.68%.
| Return on Equity (ROE) | -183.30% |
| Return on Assets (ROA) | -134.10% |
| Return on Capital (ROIC) | -168.68% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.28M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -80.14% in the last 52 weeks. The beta is 1.53, so ADIL's price volatility has been higher than the market average.
| Beta (1Y) | 1.53 |
| 52-Week Price Change | -80.14% |
| 50-Day Moving Average | 1.82 |
| 200-Day Moving Average | 2.38 |
| Relative Strength Index (RSI) | 45.44 |
| Average Volume (30 Days) | 6,646,501 |
Short Selling Information
The latest short interest is 1.01 million, so 24.90% of the outstanding shares have been sold short.
| Short Interest | 1.01M |
| Short Previous Month | 8,655 |
| Short % of Shares Out | 24.90% |
| Short % of Float | 25.64% |
| Short Ratio (days to cover) | 0.14 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -6.89M |
| Pretax Income | -5.12M |
| Net Income | -5.12M |
| EBITDA | -5.12M |
| EBIT | -5.12M |
| Earnings Per Share (EPS) | -$3.60 |
Balance Sheet
The company has $2.83 million in cash and no debt, giving a net cash position of $2.83 million or $0.70 per share.
| Cash & Cash Equivalents | 2.83M |
| Total Debt | n/a |
| Net Cash | 2.83M |
| Net Cash Per Share | $0.70 |
| Equity / Book Value | 4.08M |
| Book Value Per Share | 1.01 |
| Working Capital | 2.55M |
Cash Flow
| Operating Cash Flow | -6.81M |
| Capital Expenditures | n/a |
| Free Cash Flow | -6.81M |
| FCF Per Share | -$4.78 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ADIL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -42.25% |
| Shareholder Yield | -42.25% |
| Earnings Yield | -82.05% |
| FCF Yield | -109.01% |
Analyst Forecast
The average price target for ADIL is $150.00, which is 9,454.14% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $150.00 |
| Price Target Difference | 9,454.14% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -49.15% |
Stock Splits
The last stock split was on August 7, 2023. It was a reverse split with a ratio of 1:25.
| Last Split Date | Aug 7, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |